K
51
-2
TGNA
53
-3
PSX
50
-2
SLG
55
-4
O
20
-2
FDX
30
-7
EXPD
47
-3
NUE
58
-2
GILD
54
-2
STX
45
-11
CHRW
47
5
KLAC
61
2
VRTX
52
-2
WDC
60
-3
WY
57
-2
DAL
70
-6
ADM
33
-4
CMG
66
2
AIZ
80
2
SJM
29
-4
K
51
-2
TGNA
53
-3
PSX
50
-2
SLG
55
-4
O
20
-2
FDX
30
-7
EXPD
47
-3
NUE
58
-2
GILD
54
-2
STX
45
-11
CHRW
47
5
KLAC
61
2
VRTX
52
-2
WDC
60
-3
WY
57
-2
DAL
70
-6
ADM
33
-4
CMG
66
2
AIZ
80
2
SJM
29
-4
Financhill
Back

Karyopharm Therapeutics Vs. PTC Therapeutics Industry Stock Comparison

Sell
34

KPTI
Karyopharm Therapeutics

Last Price:
0.81
Seasonality Move:
8.59%
Sell
47

PTCT
PTC Therapeutics

Last Price:
50.34
Seasonality Move:
17.12%
Sell
34
Karyopharm Therapeutics (KPTI) is a Sell

Is Karyopharm Therapeutics a Buy, Sell or Hold?

  • The current Karyopharm Therapeutics [KPTI] share price is $0.81. The Score for KPTI is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • KPTI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KPTI Stock Price Chart

What is Karyopharm Therapeutics's stock price today?

  • The Karyopharm Therapeutics share price today is $0.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $50.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.

KPTI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: -673536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.8 - 0.9) Sell
Bollinger Bands (100): (0.76 - 0.92) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.11 Buy
Relative Strength Index (14 RSI): 66.75 Buy
Chaikin Money Flow: -849912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.04 - 46.16) Buy
Bollinger Bands (100): (32.47 - 41.53) Buy

KPTI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.83 Sell
20-day SMA: 0.84 Sell
50-day SMA: 0.84 Sell
200-day SMA: 1 Sell
8-day EMA: 0.83 Sell
20-day EMA: 0.84 Sell
50-day EMA: 0.84 Sell
200-day EMA: 1 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.81 Buy
20-day SMA: 43.67 Buy
50-day SMA: 40.62 Buy
200-day SMA: 34.19 Buy
8-day EMA: 46.55 Buy
20-day EMA: 44.07 Buy
50-day EMA: 41.1 Buy
200-day EMA: 35.83 Buy

Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.

Karyopharm Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):